Free Trial

Estée Lauder Companies (EL) Competitors

Estée Lauder Companies logo
$64.47 +0.81 (+1.27%)
Closing price 05/22/2025 03:59 PM Eastern
Extended Trading
$64.97 +0.51 (+0.79%)
As of 06:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EL vs. PBH, IPAR, HLF, USNA, NUS, NATR, MED, VERU, CL, and HLN

Should you be buying Estée Lauder Companies stock or one of its competitors? The main competitors of Estée Lauder Companies include Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Colgate-Palmolive (CL), and Haleon (HLN).

Estée Lauder Companies vs.

Prestige Consumer Healthcare (NYSE:PBH) and Estée Lauder Companies (NYSE:EL) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, community ranking, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

Prestige Consumer Healthcare has a beta of 0.44, meaning that its stock price is 56% less volatile than the S&P 500. Comparatively, Estée Lauder Companies has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.

Estée Lauder Companies received 701 more outperform votes than Prestige Consumer Healthcare when rated by MarketBeat users. However, 70.14% of users gave Prestige Consumer Healthcare an outperform vote while only 67.63% of users gave Estée Lauder Companies an outperform vote.

CompanyUnderperformOutperform
Prestige Consumer HealthcareOutperform Votes
498
70.14%
Underperform Votes
212
29.86%
Estée Lauder CompaniesOutperform Votes
1199
67.63%
Underperform Votes
574
32.37%

Estée Lauder Companies has higher revenue and earnings than Prestige Consumer Healthcare. Estée Lauder Companies is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prestige Consumer Healthcare$1.14B3.69$209.34M$4.2919.79
Estée Lauder Companies$14.79B1.57$390M-$2.42-26.64

Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 2.2%. Estée Lauder Companies pays an annual dividend of $1.40 per share and has a dividend yield of 2.2%. Prestige Consumer Healthcare pays out 44.3% of its earnings in the form of a dividend. Estée Lauder Companies pays out -57.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, Estée Lauder Companies had 20 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 29 mentions for Estée Lauder Companies and 9 mentions for Prestige Consumer Healthcare. Prestige Consumer Healthcare's average media sentiment score of 1.31 beat Estée Lauder Companies' score of 1.25 indicating that Prestige Consumer Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Prestige Consumer Healthcare
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Estée Lauder Companies
24 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

Prestige Consumer Healthcare presently has a consensus target price of $93.33, indicating a potential upside of 9.95%. Estée Lauder Companies has a consensus target price of $75.20, indicating a potential upside of 16.65%. Given Estée Lauder Companies' higher probable upside, analysts plainly believe Estée Lauder Companies is more favorable than Prestige Consumer Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prestige Consumer Healthcare
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Estée Lauder Companies
0 Sell rating(s)
18 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.18

99.9% of Prestige Consumer Healthcare shares are owned by institutional investors. Comparatively, 55.2% of Estée Lauder Companies shares are owned by institutional investors. 1.6% of Prestige Consumer Healthcare shares are owned by company insiders. Comparatively, 12.8% of Estée Lauder Companies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Prestige Consumer Healthcare has a net margin of 19.13% compared to Estée Lauder Companies' net margin of -4.61%. Estée Lauder Companies' return on equity of 16.82% beat Prestige Consumer Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Prestige Consumer Healthcare19.13% 12.36% 6.39%
Estée Lauder Companies -4.61%16.82%4.00%

Summary

Prestige Consumer Healthcare and Estée Lauder Companies tied by winning 10 of the 20 factors compared between the two stocks.

Get Estée Lauder Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for EL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EL vs. The Competition

MetricEstée Lauder CompaniesToilet preparations IndustryStaples SectorNYSE Exchange
Market Cap$22.90B$11.73B$17.49B$19.30B
Dividend Yield2.12%3.46%3.07%3.83%
P/E Ratio-33.0617.8716.3134.53
Price / Sales1.574.374.2134.84
Price / Cash14.5417.9016.3917.51
Price / Book5.5512.316.144.69
Net Income$390M$332.81M$737.42M$1.02B
7 Day Performance-1.10%-0.28%-1.76%-2.43%
1 Month Performance12.45%3.50%1.91%6.27%
1 Year Performance-48.90%-8.78%-2.49%5.78%

Estée Lauder Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EL
Estée Lauder Companies
4.2684 of 5 stars
$64.47
+1.3%
$75.20
+16.6%
-50.7%$22.90B$14.79B-33.0663,000Positive News
PBH
Prestige Consumer Healthcare
3.6948 of 5 stars
$88.65
-0.5%
$93.33
+5.3%
+31.1%$4.38B$1.14B20.76540Positive News
IPAR
Inter Parfums
3.9585 of 5 stars
$127.83
+0.9%
$157.60
+23.3%
+11.0%$4.11B$1.47B27.43530Trending News
Analyst Revision
HLF
Herbalife
4.5012 of 5 stars
$6.96
-1.4%
$11.50
+65.2%
-38.3%$708.86M$4.95B2.8010,100Analyst Downgrade
USNA
USANA Health Sciences
4.2847 of 5 stars
$30.03
-0.8%
$36.00
+19.9%
-38.1%$559.25M$876.24M10.611,900Analyst Upgrade
NUS
Nu Skin Enterprises
3.087 of 5 stars
$7.47
-1.5%
$6.88
-8.0%
-46.2%$371.43M$1.68B-2.5313,400Positive News
NATR
Nature's Sunshine Products
2.7467 of 5 stars
$14.85
-0.1%
$18.33
+23.5%
-7.6%$272.51M$456.62M16.88850
MED
Medifast
3.3694 of 5 stars
$14.09
+0.7%
$16.50
+17.1%
-45.2%$154.86M$543.45M78.28870Positive News
Analyst Revision
VERU
Veru
1.5052 of 5 stars
$0.52
0.0%
$4.00
+670.3%
-64.2%$76.12M$16.89M-2.00230
CL
Colgate-Palmolive
4.5764 of 5 stars
$91.39
+0.2%
$102.12
+11.7%
-4.1%$74.06B$19.95B25.9633,800Positive News
HLN
Haleon
2.4806 of 5 stars
$10.87
+0.6%
$11.25
+3.5%
+30.0%$49.00B$11.23B31.9725,408Positive News
Upcoming Earnings
Analyst Downgrade

Related Companies and Tools


This page (NYSE:EL) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners